Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population

被引:89
作者
Benetos, A [1 ]
Thomas, F [1 ]
Bean, KE [1 ]
Guize, L [1 ]
机构
[1] Ctr Invest Prevent & Clin, F-75116 Paris, France
关键词
hypertension; antithypertensive treatment; cardiovascular risk factors; systolic blood pressure;
D O I
10.1097/00004872-200309000-00011
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Objective The aim of the present study was to assess whether increased cardiovascular mortality in treated hypertensives could be explained by high blood pressure levels, or by the presence of associated risk factors and/or associated diseases. Design The study sample consisted of 8893 treated hypertensive men and women from the Investigations Preventives et Cliniques cohort, and 25 880 gender-matched and age-matched untreated subjects from the same cohort. Vital status was obtained for an 8-12 year period. Results Treated hypertensive subjects had higher systolic blood pressure (SBP) (+ 15 mmHg) and higher diastolic blood pressure (+ 9 mmHg), and a higher prevalence of associated risk factors and diseases. Treated hypertensives compared with untreated subjects presented a two-fold increase in the risk ratio (RR) for cardiovascular mortality [RR, 1.96; 95% confidence interval (CI), 1.74-2.22] and coronary mortality (RR, 1.99; 95% CI, 1.63-2.44). Adjustment for unmodifiable risk factors decreased the excess cardiovascular risk observed in treated subjects only slightly: RR, 1.77; 95% CI, 1.56-2.00 for cardiovascular mortality; and RR, 1.76; 95% CI, 1.44-2.16 for coronary mortality. After additional adjustment for modifiable associated risk factors, the increased mortality in treated subjects persisted: RR, 1.52; 95% CI, 1.33-1.74 for cardiovascular mortality; and RR, 1.49; 95% CI, 1.19-1.86 for coronary mortality. Only after additional adjustment for SBP were cardiovascular mortality and coronary mortality similar in the two groups of subjects: RR, 1.06; 95% CI, 0.92-1.23; and RR, 1.06; 95% CI, 0.85-1.35, respectively. Conclusions The increased cardiovascular mortality in treated hypertensive subjects as compared with untreated subjects is mainly due to high SBP levels under treatment. This result suggests that the excess risk found in treated hypertensives may be drastically reduced if SBP were brought under control. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:1635 / 1640
页数:6
相关论文
共 14 条
[1]
Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S .
JOURNAL OF HYPERTENSION, 1998, 16 (06) :761-769
[2]
Survival in treated hypertension: follow up study after two decades [J].
Andersson, OK ;
Almgren, T ;
Persson, B ;
Samuelsson, O ;
Hedner, T ;
Wilhelmsen, L .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7152) :167-171
[3]
A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men [J].
Benetos, A ;
Zureik, M ;
Morcet, J ;
Thomas, F ;
Bean, K ;
Safar, M ;
Ducimetière, P ;
Guize, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :673-680
[4]
Prognostic value of systolic and diastolic blood pressure in treated hypertensive men [J].
Benetos, A ;
Thomas, F ;
Bean, K ;
Gautier, S ;
Smulyan, H ;
Guize, L .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (05) :577-581
[5]
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[6]
TRENDS IN THE PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE ADULT US POPULATION - DATA FROM THE HEALTH EXAMINATION SURVEYS, 1960 TO 1991 [J].
BURT, VL ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D ;
WHELTON, P ;
BROWN, C ;
ROCCELLA, EJ .
HYPERTENSION, 1995, 26 (01) :60-69
[7]
Chalmers J, 1999, J HYPERTENS, V17, P151
[8]
Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium [J].
Fagard, RH ;
Van den Enden, M ;
Leeman, M ;
Warling, X .
JOURNAL OF HYPERTENSION, 2002, 20 (07) :1297-1302
[9]
Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study [J].
Franklin, SS ;
Khan, SA ;
Wong, ND ;
Larson, MG ;
Levy, D .
CIRCULATION, 1999, 100 (04) :354-360
[10]
MORTALITY IN PATIENTS OF THE GLASGOW BLOOD-PRESSURE CLINIC [J].
ISLES, CG ;
WALKER, LM ;
BEEVERS, GD ;
BROWN, I ;
CAMERON, HL ;
CLARKE, J ;
HAWTHORNE, V ;
HOLE, D ;
LEVER, AF ;
ROBERTSON, JWK ;
WAPSHAW, JA .
JOURNAL OF HYPERTENSION, 1986, 4 (02) :141-156